This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignee: Rutgers, The State University of New Jersey. Active years: 2018-2025.
Location History:
- Bridgewater, NJ (US) (2020)
- Monroe, NJ (US) (2018 - 2023)
Company Filing History:
Years Active: 2018-2025
Title: Atif J Khan: Innovator in Tumor Treatment
Introduction
Atif J Khan is a notable inventor based in Monroe, NJ (US), recognized for his contributions to the field of cancer treatment. With a total of five patents to his name, he has made significant strides in enhancing tumor sensitivity to ionizing radiation.
Latest Patents
One of his latest patents involves a combination therapy using riluzole to enhance tumor sensitivity to ionizing radiation. This method includes administering riluzole in an effective amount to sensitize tumor cells to ionizing radiation, followed by irradiating the tumor cells with a dose effective to reduce tumor cell growth. The method may also include administering one or more additional therapeutic agents to improve treatment outcomes.
Career Highlights
Atif J Khan is affiliated with Rutgers, the State University of New Jersey, where he continues to advance research in oncology. His work focuses on innovative approaches to cancer treatment, particularly in improving the efficacy of existing therapies.
Collaborations
He collaborates with esteemed colleagues such as Suzie Chen and James S Goydos, contributing to a dynamic research environment that fosters innovation in cancer therapies.
Conclusion
Atif J Khan's work exemplifies the intersection of innovation and medical research, particularly in the fight against cancer. His patents reflect a commitment to improving patient outcomes through advanced therapeutic methods.